Furthermore, our results that CBD disrupted cholesterol trafficking through lysosomes, when in combination with U18666A, raises the question of whether CBD use might increase the risk of toxicity in patients with Niemann–Pick disease type C, which harbor mutations in NPC1, the target of U18666A (116). Here, NPC1 is linked to Niemann-Pick disease type C.